Cargando…
De-Escalation of P2Y(12) Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention
Dual antiplatelet therapy (DAPT) — a combination of a P2Y(12) receptor inhibitor and aspirin — has revolutionized antithrombotic treatment. Potent P2Y(12) inhibitors such as prasugrel and ticagrelor exhibit a strong and more consistent platelet inhibition when compared to clopidogrel. Therefore, tic...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Society of Cardiology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158449/ https://www.ncbi.nlm.nih.gov/pubmed/30238704 http://dx.doi.org/10.4070/kcj.2018.0255 |